In the 10th episode of the ALADDIN podcast, our host Sara welcomes Dr Ameeta Retzer & Dr Victoria Forster to discuss patient reported outcomes (PROs) and the role of patient engagement in paediatric oncology research.

In this episode of the ALADDIN podcast, expert advocates Nick Bird, Nicole Scobie and Antonia Palmer share their experiences of engaging in drug development research.

In this episode of the ALADDIN podcast, host Sara sits down with Professor of paediatric oncology Pam Kearns, and expert patient advocate Donna Ludwinski to discuss the role of academic clinical trials in developing new medicines for children with cancer.

Prof Michel Zwaan is a paediatric oncologist working in the Prinses Maxima Centrum in the Netherlands. In this episode, he discusses the involvement of the pharmaceutical industry in researching new drugs for children with cancer.

What is Health Technology Assessment and why is it important for developing new medicines?

In this episode of the ALADDIN podcast, Prof. Gilles Vassal gives some insight in preparation for the next public ALADDIN webinar on HTAs.

Secure your place at the webinar today: https://portal.aladdin-education.eu/webinar/108

In this episode, Sara chats with Delphine Heenen & Dr. Davy Chiodin about how innovative approaches like repurposing drugs and rescuing shelved drugs can bring solutions in the development of paediatric drugs.

In this episode of the ALADDIN podcast, we talk to paediatric oncologists Dr Steve DuBois and Dr Julia Glade-Bender about the challenges of delivering clinical trials for children with cancer.

In this episode, our host Sara chats to some of the students involved in the various ALADDIN activities about their learnings and experience in the programme so far.

In this month's episode, our host Sara speaks to patient engagement and involvement expert Begonya Nafira. Begonya is based at the Sant Joan de Déu Hospital in Barcelona, and coordinates their patient engagement programme for children's clinical trials.

In our very first episode, ALADDIN Coordinator Dr Teresa De Rojas gives an overview of the programme and how it has developed so far.